After three major US companies - Boeing, Abbott and Honeywell -
auto major Maruti Suzuki has now come in support of India's
intellectual property rights (IPR) regime, saying the "very
strong" domestic laws are on par with international standards.
Month back, American pharma sector had alleged that Indian IPR laws
discriminate against US companies and violate global norms. Maruti
Suzuki India (MSI) firmly believes that the patent law in India is
very strong; especially the changes that happened after the TRIPS
agreement have made Indian Patent law at par with the international
standards," the company said in its views submitted to the
Commerce and Industry Ministry. According to MSI, many recent
judgments have proved that strong patent law not only secures the
rights of patentee, but also ensures genuine public need. The IPR
law in India provides transparent system of securing and enforcing
the patent rights.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
To print this article, all you need is to be registered on Mondaq.com.
Click to Login as an existing user or Register so you can print this article.
This article enunciates the recent, much awaited, and landmark judgment delivered on September 16, 2016 by Hon'ble Delhi High Court throwing light on the important provisions of the Copyright Act, 1962.
Department of Industrial Policy and Promotion recently issued an office memorandum pursuant to receiving representations from various stakeholders for guidance with respect to the applicability of the provisions of Section 31D of the Copyright Act, 1957.
An Invention Disclosure Form is the documentation of the invention. This is a means to document particulars of your invention and submitting it to the patent attorney who is filing your patent application.
The Patents Act 1970, along with the Patents Rules 1972, came into force on 20th April 1972, replacing the Indian Patents and Designs Act 1911. The Patents Act was largely based on the recommendations of the Ayyangar Committee Report headed by Justice N. Rajagopala Ayyangar. One of the recommendations was the allowance of only process patents with regard to inventions relating to drugs, medicines, food and chemicals.
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).